SLP
Simulations Plus, Inc.
A maker of computer software that lets pharmaceutical companies test drugs "on screen" before they ever reach a lab or a patient. Its tools—like GastroPlus, ADMET Predictor, and DILIsym—predict how a compound moves through the body and whether it might harm the liver, and its services help with modeling and clinical trial training. Founder Walt Woltosz started the company in 1996 after bringing aerospace-style simulation ideas into drug development. Its name simply joins "simulations" with a "plus," a nod to the extra technology baked in.
CUSIP: 829214105HealthcareUS1 holder
Total Value
$8.77M
Total Shares
742.1K
Net Share Change
+284.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
